4-hydroxy-3-methoxybenzoic acid benzyl ester

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-hydroxy-3-methoxybenzoic acid benzyl ester
• 英文别名: benzyl 4-hydroxy-3-methoxybenzoate；4-Hydroxy-3-methoxy-benzoesaeure-benzylester；Vanillinsaeure-benzylester；Benzyl vanillate
• 化学式: C₁₅H₁₄O₄
• 分子量: 258.274
• InChiKey: IQCJHZALQHFXDP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  55.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-hydroxy-3-methoxybenzoic acid benzyl ester 在 4-二甲氨基吡啶 、 palladium 10% on activated carbon 、 甲酸铵 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 46.0h， 生成 3-methoxy-4-sulfooxybenzoic acid monoammonium salt
  参考文献：
  名称：

  Flavonoid metabolism: the synthesis of phenolic glucuronides and sulfates as candidate metabolites for bioactivity studies of dietary flavonoids

  摘要：

  Epidemiological studies indicate that flavonoid intake is inversely associated with the risk of coronary heart disease, yet the mechanisms responsible for their bioactivity are still a matter of debate. Based on the rapid and extensive metabolism of most flavonoids, their health effects most likely result from the biological activity of their metabolites. However, a lack of commercially available compounds/standards has prevented the study of metabolite bioactivity and resulted in a focus on non-physiologically relevant precursor/parent structures. This paper details the synthesis of a series of phenolic glucuronide 1a-e and sulfate 2a-e derivates as candidate metabolites for use as reference compounds in metabolic profiling studies and for the exploration of flavonoid bioactivity. (C) 2012 Published by Elsevier Ltd.

  DOI：

  10.1016/j.tet.2012.03.100
• 作为产物：
  描述：

  香草酸 、 溴甲苯 在 caesium carbonate 作用下， 以 甲醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 0.5h， 以12%的产率得到4-hydroxy-3-methoxybenzoic acid benzyl ester
  参考文献：
  名称：

  [EN] ANTIVIRAL COMPOUNDS
  [FR] COMPOSÉS ANTIVIRAUX

  摘要：

  本文披露了新的抗病毒化合物，以及包括一种或多种抗病毒化合物的药物组合物，以及合成这些化合物的方法。本文还披露了使用一种或多种小分子化合物改善和/或治疗副粘病毒病毒感染的方法。副粘病毒感染的例子包括由人类呼吸道合胞病毒（RSV）引起的感染。

  公开号：

  WO2015026792A1

文献信息

• [EN] ANTIVIRAL COMPOUNDS<br/>[FR] COMPOSÉS ANTIVIRAUX
  申请人：ALIOS BIOPHARMA INC

  公开号：WO2015026792A1

  公开（公告）日：2015-02-26

  Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).

  本文披露了新的抗病毒化合物，以及包括一种或多种抗病毒化合物的药物组合物，以及合成这些化合物的方法。本文还披露了使用一种或多种小分子化合物改善和/或治疗副粘病毒病毒感染的方法。副粘病毒感染的例子包括由人类呼吸道合胞病毒（RSV）引起的感染。
• New Reagents for the Synthesis of Arylmethyl Ethers and Esters
  作者：Gregory Dudley、Philip Albiniak

  DOI：10.1055/s-0029-1219531

  日期：2010.4

  developmentof new arylmethyl transfer (benzylation) reagents for protectingoxygen functional groups under relatively mild and neutral conditions.It begins with an investigation of organosiletanes as surrogatehydroxyl groups, which inspired siletane-functionalized benzyl ethersand forced us to confront the difficulties associated with the synthesisof benzyl ethers. The end result is a new series of neutral oxypyridiniumsalts

  该帐户记录了导致开发新的芳甲基转移（苄基化）试剂在相对温和和中性条件下保护氧官能团的努力。它从作为替代羟基的有机硅酮的研究开始，它启发了硅烷官能化的苄基醚并迫使我们面对与苄基醚合成相关的困难。最终结果是一系列新的中性氧吡啶鎓盐，用于在温和条件下对各种亲核官能团进行苄基化。1 引言 2 应变有机硅烷的 Tamao 型氧化 3 P-Siletanylbenzyl (PSB) 保护基团 4 2-Benzyloxy-1-methylpyridinium Triflate 5 Friedel-Crafts 反应和机理洞察 6 苄酯形成 7 取代的 Benz8 转移试剂和展望
• Synthesis of New Sulfated and Glucuronated Metabolites of Dietary Phenolic Compounds Identified in Human Biological Samples
  作者：A. Filipa Almeida、Cláudia N. Santos、M. Rita Ventura

  DOI：10.1021/acs.jafc.6b05629

  日期：2017.8.9

  standards has hampered the study of metabolite bioactivity and the exact structural confirmation in biological samples. New (poly)phenol metabolites previously identified in human samples after the intake of berry juice were chemically synthesized. Efficient chemical reactions were performed with moderate to excellent yields and selectivities. These new compounds could be used as standard chemicals

  （多）酚是水果和蔬菜中的一大类饮食化合物；它们的食用与有益健康有关。摄入后，（多）苯酚遭受广泛的代谢，其代谢产物的鉴定是一个新兴领域，因为这些代谢产物被认为是人类有机体中有效的生物活性分子。然而，缺乏可商购的标准阻碍了代谢物生物活性的研究以及生物样品中确切的结构确认。摄入浆果汁后，先前在人体样品中鉴定出的新的（多）苯酚代谢物是化学合成的。以中等至极好的产率和选择性进行了有效的化学反应。
• [EN] SUBSTITUTED PYRIDINE CARBOXYLIC ACIDS, THEIR PREPARATION METHOD AND COMPOSITIONS THEREOF<br/>[FR] ACIDES PYRIDINECARBOXYLIQUES SUBSTITUÉS, LEUR PROCÉDÉ DE PRÉPARATION ET COMPOSITIONS ASSOCIÉES
  申请人：INCILIA THERAPEUTICS PRIVATE LTD

  公开号：WO2020100169A1

  公开（公告）日：2020-05-22

  The present invention relates to novel substituted pyridine carboxylic acid derivatives and their preparation methods. This invention is also directed to pharmaceutical compositions containing such compounds and combinations thereof with at least one therapeutic agent. These substituted pyridine carboxylic acid compounds and their pharmaceutical acceptable salts and esters are useful in the treatment or control of various metabolic disorders.

  本发明涉及新型的取代吡啶羧酸衍生物及其制备方法。本发明还涉及含有这种化合物和至少一种治疗剂的药物组合物。这些取代吡啶羧酸化合物及其药物可接受的盐和酯在治疗或控制各种代谢性疾病方面是有用的。
• ANTIVIRAL COMPOUNDS
  申请人：Alios BioPharma, Inc.

  公开号：US20150065504A1

  公开（公告）日：2015-03-05

  Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).

  本文披露了新的抗病毒化合物，以及包括一种或多种抗病毒化合物的制药组合物和合成方法。本文还披露了使用一种或多种小分子化合物改善和/或治疗副黏液病毒病毒感染的方法。副黏液病毒感染的例子包括由人类呼吸道合胞病毒(RSV)引起的感染。